SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016507
Filing Date
2017-08-08
Accepted
2017-08-08 16:07:30
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arna-10q_20170630.htm 10-Q 1595386
2 EX-10.7 arna-ex107_6.htm EX-10.7 26056
3 EX-31.1 arna-ex311_8.htm EX-31.1 15032
4 EX-31.2 arna-ex312_9.htm EX-31.2 15410
5 EX-32.1 arna-ex321_10.htm EX-32.1 8786
  Complete submission text file 0001564590-17-016507.txt   5294695

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arna-20170630.xml EX-101.INS 1068002
7 XBRL TAXONOMY EXTENSION SCHEMA arna-20170630.xsd EX-101.SCH 42298
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20170630_cal.xml EX-101.CAL 40440
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20170630_def.xml EX-101.DEF 139019
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20170630_lab.xml EX-101.LAB 305266
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20170630_pre.xml EX-101.PRE 229807
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 171014767
SIC: 2834 Pharmaceutical Preparations